David D. Allison - Jan 6, 2023 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 6, 2023
Transactions value $
$12,502
Form type
4
Date filed
1/10/2023, 03:18 PM
Previous filing
Oct 12, 2022
Next filing
Feb 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $12.5K +1.5K $8.34 1.5K Jan 6, 2023 Common Stock 1.5K $11.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.